DK200100341A - Fremgangsmåde til fremstilling af farmaceutiske tabletter indeholdende paroxetinhydrochlorid-anhydrat - Google Patents

Fremgangsmåde til fremstilling af farmaceutiske tabletter indeholdende paroxetinhydrochlorid-anhydrat Download PDF

Info

Publication number
DK200100341A
DK200100341A DK200100341A DKPA200100341A DK200100341A DK 200100341 A DK200100341 A DK 200100341A DK 200100341 A DK200100341 A DK 200100341A DK PA200100341 A DKPA200100341 A DK PA200100341A DK 200100341 A DK200100341 A DK 200100341A
Authority
DK
Denmark
Prior art keywords
paroxetine hydrochloride
hydrochloride anhydrate
tablets containing
preparation
pharmaceutical tablets
Prior art date
Application number
DK200100341A
Other languages
Danish (da)
English (en)
Inventor
Felumb Niels Christian
Henriksen Kristian Lund
Pedersen Soeren Bols
Original Assignee
Gea Farmaceutisk Fabrik As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gea Farmaceutisk Fabrik As filed Critical Gea Farmaceutisk Fabrik As
Priority to DK200100341A priority Critical patent/DK200100341A/da
Priority to PT02700190T priority patent/PT1363633E/pt
Priority to ES02700190T priority patent/ES2239707T3/es
Priority to US10/469,031 priority patent/US20040072912A1/en
Priority to EP02700190A priority patent/EP1363633B1/de
Priority to DK02700190T priority patent/DK1363633T3/da
Priority to PCT/DK2002/000134 priority patent/WO2002069969A1/en
Priority to SI200230154T priority patent/SI1363633T1/xx
Priority to AT02700190T priority patent/ATE294580T1/de
Priority to AU2002233182A priority patent/AU2002233182B2/en
Priority to DE60203997T priority patent/DE60203997T2/de
Priority to CA002439460A priority patent/CA2439460A1/en
Publication of DK200100341A publication Critical patent/DK200100341A/da
Priority to NO20033855A priority patent/NO20033855D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK200100341A 2001-03-02 2001-03-02 Fremgangsmåde til fremstilling af farmaceutiske tabletter indeholdende paroxetinhydrochlorid-anhydrat DK200100341A (da)

Priority Applications (13)

Application Number Priority Date Filing Date Title
DK200100341A DK200100341A (da) 2001-03-02 2001-03-02 Fremgangsmåde til fremstilling af farmaceutiske tabletter indeholdende paroxetinhydrochlorid-anhydrat
DK02700190T DK1363633T3 (da) 2001-03-02 2002-03-01 Vådgranulerings-fremgangsmåde til fremstilling af farmaceutiske tabletter indeholdende paroxetinhydrochlorid-anhydrat
ES02700190T ES2239707T3 (es) 2001-03-02 2002-03-01 Procedimiento de granulacion por via humeda para la preparacion de tabletas farmaceuticas que contienen anhidrato de hidrocloruro de paroxetina.
US10/469,031 US20040072912A1 (en) 2001-03-02 2002-03-01 Process for the manufacture of pharmaceutical tablets contaning paroxetine hydrochloride anhydrate
EP02700190A EP1363633B1 (de) 2001-03-02 2002-03-01 Nasses granulationsverfahren zur herstellung von pharmazeutischen tabletten mit paroxetinhydrochlorid anhydrat
PT02700190T PT1363633E (pt) 2001-03-02 2002-03-01 Processo de granulacao humido para a preparacao de comprimidos farmaceuticos contendo anidrato do cloridrato de paroxetina
PCT/DK2002/000134 WO2002069969A1 (en) 2001-03-02 2002-03-01 A process for the manufacture of pharmaceutical tablets containing paroxetine hydrochloride anhydrate
SI200230154T SI1363633T1 (en) 2001-03-02 2002-03-01 A wet granulation process for the manufacture of pharmaceutical tablets containing paroxetine hydrochloride anhydrate
AT02700190T ATE294580T1 (de) 2001-03-02 2002-03-01 Nasses granulationsverfahren zur herstellung von pharmazeutischen tabletten mit paroxetinhydrochlorid anhydrat
AU2002233182A AU2002233182B2 (en) 2001-03-02 2002-03-01 A process for the manufacture of pharmaceutical tablets containing paroxetine hydrochloride anhydrate
DE60203997T DE60203997T2 (de) 2001-03-02 2002-03-01 Nasses granulationsverfahren zur herstellung von pharmazeutischen tabletten mit paroxetinhydrochlorid anhydrat
CA002439460A CA2439460A1 (en) 2001-03-02 2002-03-01 A process for the manufacture of pharmaceutical tablets containing paroxetine hydrochloride anhydrate
NO20033855A NO20033855D0 (no) 2001-03-02 2003-09-01 Fremgangsmåte ved fremstilling av farmasöytiske tabletter inneholdende paroxetinhydrokloridanhydrat

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK200100341A DK200100341A (da) 2001-03-02 2001-03-02 Fremgangsmåde til fremstilling af farmaceutiske tabletter indeholdende paroxetinhydrochlorid-anhydrat

Publications (1)

Publication Number Publication Date
DK200100341A true DK200100341A (da) 2002-09-03

Family

ID=8160333

Family Applications (2)

Application Number Title Priority Date Filing Date
DK200100341A DK200100341A (da) 2001-03-02 2001-03-02 Fremgangsmåde til fremstilling af farmaceutiske tabletter indeholdende paroxetinhydrochlorid-anhydrat
DK02700190T DK1363633T3 (da) 2001-03-02 2002-03-01 Vådgranulerings-fremgangsmåde til fremstilling af farmaceutiske tabletter indeholdende paroxetinhydrochlorid-anhydrat

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK02700190T DK1363633T3 (da) 2001-03-02 2002-03-01 Vådgranulerings-fremgangsmåde til fremstilling af farmaceutiske tabletter indeholdende paroxetinhydrochlorid-anhydrat

Country Status (11)

Country Link
US (1) US20040072912A1 (de)
EP (1) EP1363633B1 (de)
AT (1) ATE294580T1 (de)
AU (1) AU2002233182B2 (de)
CA (1) CA2439460A1 (de)
DE (1) DE60203997T2 (de)
DK (2) DK200100341A (de)
ES (1) ES2239707T3 (de)
NO (1) NO20033855D0 (de)
PT (1) PT1363633E (de)
WO (1) WO2002069969A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL162666A0 (en) * 2001-12-28 2005-11-20 Teva Pharma A stable pharmaceutical formulation of paroxetine hydrochloride and a process for preparation thereof
US20040208932A1 (en) * 2003-04-17 2004-10-21 Ramachandran Thembalath Stabilized paroxetine hydrochloride formulation
EP1675574A2 (de) * 2003-10-08 2006-07-05 Ranbaxy Laboratories, Ltd. Pharmazeutische zusammensetzungen von paroxetin mit mikrokristalliner cellulose, hergestellt durch nassgranulation
EP1841730A4 (de) * 2005-01-19 2010-10-27 Merck Frosst Canada Ltd Cathepsin-k-inhibitoren und atherosklerose
AU2006274565B2 (en) * 2005-08-02 2012-05-17 Lupin Limited Novel controlled release compositions of selective serotonin reuptake inhibitors
CN113350350A (zh) * 2020-03-07 2021-09-07 齐鲁制药有限公司 一种含有盐酸培唑帕尼的药物组合物的制备方法
CN113730369B (zh) * 2020-05-27 2023-07-14 石药集团欧意药业有限公司 一种阿哌沙班片剂组合物及其制备方法
CN120076787A (zh) * 2022-10-28 2025-05-30 罗盖特公司 用于配制湿气敏感性活性成分的化合物

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999048499A1 (en) * 1998-03-24 1999-09-30 Smithkline Beecham Plc Paroxetine compositions
WO2000078288A2 (en) * 1999-06-22 2000-12-28 Smithkline Beecham P.L.C. Novel process for paroxetine compositions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0149266B1 (de) * 1983-12-19 1988-05-18 Duphar International Research B.V Verfahren zum Trocknen von festen Stoffen und Vorrichtung zu dessen Ausführung
US5856493A (en) * 1995-02-06 1999-01-05 Smithkline Beecham Corporation Process for making novel form of paroxeting hydrochloride anhydrate
GB0003232D0 (en) * 2000-02-11 2000-04-05 Smithkline Beecham Plc Novel composition
US6660298B1 (en) * 2000-07-27 2003-12-09 Pentech Pharmaceuticals, Inc. Paroxetine tablets and capsules
CA2418038A1 (en) * 2000-08-28 2002-03-07 Synthon B.V. Paroxetine compositions and processes for making the same

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999048499A1 (en) * 1998-03-24 1999-09-30 Smithkline Beecham Plc Paroxetine compositions
WO2000078288A2 (en) * 1999-06-22 2000-12-28 Smithkline Beecham P.L.C. Novel process for paroxetine compositions

Also Published As

Publication number Publication date
DK1363633T3 (da) 2005-05-30
PT1363633E (pt) 2005-09-30
EP1363633B1 (de) 2005-05-04
CA2439460A1 (en) 2002-09-12
NO20033855L (no) 2003-09-01
US20040072912A1 (en) 2004-04-15
WO2002069969A1 (en) 2002-09-12
ES2239707T3 (es) 2005-10-01
AU2002233182B2 (en) 2004-10-14
ATE294580T1 (de) 2005-05-15
EP1363633A1 (de) 2003-11-26
DE60203997T2 (de) 2006-02-23
DE60203997D1 (de) 2005-06-09
NO20033855D0 (no) 2003-09-01

Similar Documents

Publication Publication Date Title
JP2009537478A5 (de)
RU2000123156A (ru) Быстро расщепляющаяся фармацевтическая лекарственная форма
RU2017133990A (ru) Фармацевтические лекарственные формы ингибитора тирозинкиназы брутона
SI2821067T1 (en) Quick spray formulation of cinacalcet
RS51527B2 (sr) Tabletna formulacija sa produženim otpuštanjem koja sadrži pramipeksol ili njegovu farmaceutski prihvatljivu so, postupak za proizvodnju iste i njena primena
DK200100341A (da) Fremgangsmåde til fremstilling af farmaceutiske tabletter indeholdende paroxetinhydrochlorid-anhydrat
KR20070093988A (ko) 라놀라진 함유 서방성 약제학적 제형물
EA029416B1 (ru) Таблетка, содержащая иматиниб или его фармацевтически приемлемую соль, и способ ее получения
SI21223A (sl) Farmacevtska formulacija s stabiliziranim amorfnim donepezilijevim kloridom
CZ2001792A3 (cs) Farmaceutická kompozice obsahující entakapon a nitakapon a zesíťovaný derivát celulózy
CA2532485A1 (en) Tablets containing ambroxol
KR20010032129A (ko) 고용량 약물 로딩 속효성 및 변형 방출형 경구 투여용제형 및 그의 제조 방법
KR20110113940A (ko) 탐술로신 또는 이의 약제학적 허용 가능한 염을 유효성분으로 한 장용성 서방형 펠렛부와 속방부로 이루어진 의약 조성물
JP2017520619A (ja) セリチニブ製剤
PL193976B1 (pl) Tabletka o przedłużonym działaniu zawierająca indapamid i sposób wytwarzania tabletki o przedłużonym działaniu zawierającej indapamid
JP2007137802A (ja) 錠剤の製造法
CZ2016553A3 (cs) Pevná farmaceutická dávková forma obsahující sofosbuvir
JP7023600B2 (ja) シロドシン含有医薬組成物とその製造方法
RU2183119C1 (ru) Фармацевтическая композиция, обладающая спазмолитической активностью, способ ее получения
Ofoefule et al. Effects of physical and chemical modifications on the disintegrant and dissolution properties of Tacca involucrata starch
SK9912003A3 (en) Pharmaceutical composition containing citalopram
US20190167592A1 (en) Process for directly compressible co-processed excipient for modified release application
KR20210024593A (ko) 도파민-β-히드록실라제 억제제를 포함하는 제제 및 이의 제조 방법
SK17142000A3 (sk) Hydrochlorid paroxetínu vo forme inej než hemihydrát formulovaný do tabliet, spôsob výroby tabliet hydrochloridu paroxetínu a súprava zahrnujúca takéto tablety
KR100679166B1 (ko) 안정성이 증진된 약제학적 조성물 및 그의 제조방법

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment